Volume 15, Number 7—July 2009
Research
Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
Isabelle Devaux
, Kristin Kremer, Herre Heersma, and Dick van Soolingen
, Kristin Kremer, Herre Heersma, and Dick van Soolingen
Table 4
Predictors for clustered MDR TB strains compared with unique strains among 521 cases reported in 16 European countries, January 2003 through June 2007*
| Variable | MDR TB strains |
Unadjusted OR (95% CI) | Adjusted† OR (95% CI) | |
|---|---|---|---|---|
| No. patients | % Clustered | |||
| Sex | ||||
| Male | 347 | 48 | 1 | 1 |
| Female |
170 |
49 |
1.0 (0.7–1.5) |
1.1 (0.6–1.9) |
| Age | ||||
| 15–44 | 324 | 43 | 1 | 1 |
| 45–64 | 143 | 61 | 2.1 (1.4–3.1) | 1.3 (0.7–2.3) |
| >65 |
36 |
53 |
1.5 (0.7–3.0) |
2.8 (0.8–9.4) |
| Origin | ||||
| Baltic states | 188 | 81 | 21.9 (10.6–44.9) | 25.1 (9.9–64.0) |
| Other FSU countries‡ | 99 | 61 | 7.7 (3.7–16.1) | 8.7 (3.2–23.2) |
| Other European countries | 72 | 17 | 1 | 1 |
| Africa |
71 |
24 |
1.6 (0.7–3.6) |
1.1 (0.4–3.5) |
| Site of disease | ||||
| Pulmonary | 473 | 50 | 2.4 (1.2–4.9) | 0.5 (0.2–1.6) |
| Extrapulmonary |
41 |
29 |
1 |
1 |
| Previous TB | ||||
| Yes | 163 | 54 | 1.0 (0.6–1.4) | 1.1 (0.6–1.9) |
| No |
248 |
55 |
1 |
1 |
| XDR TB | ||||
| Yes | 51 | 82 | 4.1 (1.9–8.7) | _ |
| No | 341 | 53 | 1 | – |
*TB, tuberculosis; MDR, multidrug-resistant; OR, odds ratio; CI, confidence interval; FSU, former Soviet Union; XDR, extensively drug-resistant. Boldface indicates significance.
†For all other factors in the model except XDR TB.
‡Former Soviet Union countries: Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Ukraine, and Uzbekistan.
Page created: November 08, 2010
Page updated: November 08, 2010
Page reviewed: November 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.